ESMO Webinar Series

Translating Immunity to Clinical Applications of Immunotherapy in Breast Cancer
Recorded live from ESMO Breast Cancer 2019
Chair: Giuseppe Curigliano

Watch now

Welcome to the ESMO Webinar on Immunotherapy in Breast Cancer

Curigliano-Guiseppe

It is with great pleasure that I invite you to participate in the ESMO Webinar entitled ‘Translating Immunity to Clinical Applications of Immunotherapy in Breast Cancer’. This webinar will go live on 3 May from ESMO Breast Cancer 2019 in Berlin.
  
Breast cancer has traditionally been considered as an immunologically silent disease. However, recent preclinical and clinical research suggests that immunotherapy can improve outcomes in a subset of breast cancer patients.
  
I am delighted to announce the lectures by three distinguished experts in the field who will join me in this webinar.
  
During the webinar, we’ll cover topics such as defining the immunogram of breast cancer, providing evidence from clinical trials with immunotherapy in breast cancer patients, as well as how to enhance immunogenicity in ‘immune excluded’ breast cancers. We will discuss various aspects of the potential and advantages of immunotherapy over conventional treatment modalities for breast cancer. 
  
The programme is designed to offer an overview of research in this area and review the current status and future prospects of immunotherapy in breast cancer.
   
I encourage you to join us in this stimulating new ESMO activity.

Giuseppe Curigliano
Istituto Europeo di Oncologia, Milan, Italy

Watch now

Programme

  • Welcome and Introduction, Giuseppe Curigliano, Istituto Europeo di Oncologia, Milan, Italy
  • Defining the Immunogram of Breast Cancer, Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Australia
  • Immunotherapy in Breast Cancer: Evidence from Clinical Trials, Peter Schmid, Barts Hospital, London, UK
  • Enhancing Immunogenicity in “Immune Excluded” or “Immune Desert” Breast Cancers, Carmen Criscitiello, Istituto Europeo di Oncologia, Milan, Italy
  • Q&A and Closing Remarks, Giuseppe Curigliano, Istituto Europeo di Oncologia, Milan, Italy

Learning objectives

  • To understand complex interactions between tumour and immune system cells in breast cancer field
  • To provide an evidence from the clinical trials on immunotherapy in breast cancer, especially in terms of targeting immune checkpoints
  • To discuss how to select the patients with breast cancer who might benefit from immunotherapy
  • To understand current landscape and future direction in terms of stimulation of immune response in breast cancer

Faculty

Giuseppe Curigliano Sherene Loi Peter Schmid Carmen Criscitiello
curigliano-giuseppe-no-bg

 

Istituto Europeo di Oncologia, Milan, Italy

loi-sherene-no-bg

 

Peter MacCallum Cancer Centre
East Melbourne, VIC, Australia

schmid-peter-no-bg

 

Barts Hospital
London, UK

criscitiello-carmen-no-bg

 

Istituto Europeo di Oncologia
Milan, Italy

Watch now

*This content is only available to ESMO members. Find out more about becoming a member.